Banner
Banner
Banner
Banner
Banner
Banner
Banner
Banner
Banner
 
Inicio
Investigacion

Investigación

Publicaciones

Unidad de Bioquímica Analítica

2013

  • J. P. Tosar, J. L. Holmes, S. D. Collyser, F. Davis, J. Laiz, S. P. Higson. Template and catalytic effects of DNA in the construction of polypyrrole/DNA composite macro and microelectrodes. Biosensors and Bioelectronics 41:294-301.

2010

  • J. P. Tosar, G. Brañas, J. Laiz. Electrochemical DNA hybridization sensors applied to real and complex biological samples. Biosensors and Bioelectronics 26(4): 1205-1217.
  • K. Keel, J. P. Tosar, J. Laiz. Desarrollo de superficies modificadas oro-anticuerpo anti PSPB para su uso como biosensor en la detección de preñez bovina. INNOTEC 5:29-33.

2009

  • J. P. Tosar, K. Keel, J. Laiz. Two independent label-free detection methods in one electrochemical DNA sensor. Biosensors and Bioelectronics. 2009; 24(10):3036-3042.

2004

  • J. Berbejillo, J. Laiz, F. Cerdá, M. Martins, E. Méndez. Topographic characterization of disposable carbon pencil modified electrodes. Portugaliae Electrochimica Acta 22 375-385.

Radiofarmacia

2013

  • 1. X. Camacho; M. F. García, V. Calzada, M. Fernández, J. A. Chabalgoity, M. Moreno, R. Barbosa de Aguiar, O. Alonso, J. P. Gambini, R. Chammas, P. Cabral [99m Tc (CO)3]-Radiolabeled Bevacizumab: In vitro and in vivo Evaluation in a Melanoma Model. Oncology, v.: 84 4 13, p.: 200-209, 2013.
  • 2. M. Cabrera, A. Medrano, N. Lecot, M. Fernández, M. Moreno, J. P. Gambini, J. A. Chabalgoity, H. Balter, O. Alonso, P. Cabral. A novel method to radiolabel stealth liposome through 1,2-dimyristoyl-sn-glycero-3-phosphoethanolamine-N-DTPA with 99mTc and biological evaluation. Analytical Oncology. v.:2 (1), 2013.
  • 3. X. Camacho, M. F. García, V. Calzada, M. Fernández, W. Porcal, O. Alonso, J. P. Gambini, P. Cabral. Synthesis and evaluation of 99mTc chelate-conjugated Bevacizumab. Current Radiopharmaceuticals, v.: 6 1 , p.: 12 - 19, 2013.

2012

  • 1. V. Calzada, X. Zhang, M. Fernández, Arlhee Díaz-Miqueli, Normando, Iznaga-Escobar, Susan L. Deutscher, H. Balter, T. P. Quinn, P. Cabral. A Potencial Theranostic Agent for EGF-R Expression Tumors: 177Lu-DOTA-Nimotuzamab. Current Radiopharmaceuticals, v.: 2, 2012.
  • 2. M. F. García, X. Camacho, V. Calzada, M. Fernández, W. Porcal, O. Alonso, J. P. Gambini, P. Cabral. Synthesis of 99mTc-Nimotuzumab with tricarbonyl ion: in vitro and in vivo studies. Current Radiopharmaceuticals, v.: 51, p.: 59 - 64, 2012.
  • 3. X. Camacho, P. Cabral. Angiogénesis Tumoral: estrategias diagnósticas y terapéuticas. Salud Militar, v.: 31 1, p.: 34 - 48, 2012.
  • 4. E. Gutiérrez, X. Camacho, V. Calzada, M. Fernández, M. F. García, W. Porcal, N. Oddone, M. Moreno, J. Benech, J. A. Chabalgoity, A. Pandiella, E. Riva, P. Cabral. 99mTc-Tocilzumab un nuevo agente de imagen molecular en Mieloma Múltiple. Salud Militar, v.: 31 1, p.: 10 - 20, 2012.
  • 5. V. Calzada, N. Lecot, M. F. García, E. Rezzano, M. L. Lavaggi, A. Gzerwonogora, H. Cerecetto, M. González, P. Cabral. Enseñanza de química en modalidad semipresencial: Nuevas experiencias. Aldeq - Anuario Latinoamericano de Educación Química, p.: 175 - 178, 2012.

Subir Subir

2011

  • 1. M. Tassano, P. Audicio, J. P. Gambini, M. Fernández, J. P. Damian, M. Moreno, J. A. Chabalgoity, J. Benech,, P. Cabral. Develment of 99mTc(CO)3-dendrimer-FITC for cancer imaging. Bioorganic & Medicinal Chemistry Letters, v.: 5598-5601, 2011.
  • 2. G. Navarro, P. Cabral, M. Cabrera, J. P. Gambini, O. Alonso, E. Savio. 99mTc-labeling and biological evaluation of conventional liposomes. ALASBIMN Journal, v. 51 13, 2011.
  • 3. J. P. Gambini, P. Cabral, O. Alonso, Said Daibes Figueroa, Xiuli Zhang, Ma. Lixin, Susan L. Deutscher, Thomas Quinn. Evaluation of 99mTc-Glucarate as a breast cancer imaging agent in a xenograft animal model. Nuclear Medicine and Biology, v.: 37 8, p.:255-260, 2011.
  • 4. P. Audicio, G. Castellano, M. Tassano, E. Riva, P. Cabral, H. Balter, P. Oliver. [177Lu]DOTA-anti-CD20: Labeling and pre-clinical studies. Applied Radiation and Isotopoes, v.: 69 7, p.: 924-928, 2011.
  • 5. M. J. Morilla, D. Mengual Gómez, P. Cabral, M. Cabrera, H. Balter, M. V. Defain Tesoriero, L. Higa, D. Roncaglia, E. L. Romero. M cells prefer archaeosomes: an in vitro/in vivo snapshot upon oral gavage in rats". Current Drug Delivery., v.: 3, p.: 320-329, 2011.
  • 6. R. Castelli, M. Fernández, W. Porcal, A. Chabalgoity, M. Moreno, P. Cabral,. Preparation and Primary Bioevaluation of 99mTc-labeled-1-thio-β-D-Glucose as Melanoma Targeting Agent. Current Radiopharmaceuticals, v.: 4 4, p.: 355-360, 2011.
  • 7. R. Dapueto Capuccion, R. Castelli, M. Fernández, J. A. Chabalgoity, M. Moreno, J. P. Gambini, P. Cabral, W. Porcal. Biological evaluation of Glucose and Deoxyglucose derivatives radiolabeled with [99mTc(CO)3(H2O)3]+ core as potential malanoma imaging agents. Bioorganic & Medicinal Chemistry Letters, v.: 21, p.: 7102-7106, 2011.
  • 8. M. J. Morilla, M. D. Gómez, P. Cabral, M. Cabrera, H. Balter, V. D. Tesoriero, L. Higa, D. Roncaglia, E. Romero. M Cells Prefer Archaeosomes: An In Vitro/In Vivo Snapshot Upon Oral Gavage in Rats. CUrrent Drug Delivery., v. 8 3 10, p. 320-329, 2011.

2010

  • 1. X. Zang, P. Cabral, T. Quinn, V. Calzada, J. P. Gambini, H. Balter, S. L. Deutscher. In vitro and in vivo evaluation of [99mTc(CO)3]-radiolabeled ErbB-2-targeting peptides for breast carcinoma imaging. Current Radiopharmaceuticals, v.: 3 4, p.: 308-321, 2010.

Subir Subir